title: Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.
abstract: Recent studies have considered the qualitative and quantitative assessment of salivary flow, as well the biochemical components of saliva, as possible biomarkers that might contribute to the pathogenesis of chronic graft-versus-host disease (cGHVD) in hematopoietic stem cell transplantation (HSCT) patients. The aim of this study was to evaluate prospectively the inorganic salivary status at different periods of allogeneic HSCT. Saliva collection and oral examination were performed prior to the HSCT, ​between days 8 and 10, days 80 and 100, and at the cGVHD onset. Concentrations of calcium (Ca), phosphate (Pi), chloride (Cl), magnesium (Mg), potassium (K), and sodium (Na) were performed using colorimetric reactions and atomic absorption. Fifty-five consecutive patients undergoing first allogeneic HSCT were included in this study. Between days 8 and 10, the salivary flow rate was significantly higher (p = 0.05), Pi concentration was decreased (p = 0.007), and Na and Cl were increased (p = 0.001 and p = 0.001, respectively), compared with the baseline. Salivary flow rate during the same period showed a negative correlation with Pi concentration (p = 0.02) and a positive correlation with Na and Cl concentrations (p = 0.003 and p = 0.001, respectively). The salivary flow rate was decreased between days 80 and 100 (p = 0.02) and Na, Cl, and K concentrations were increased (p = 0.03, p = 0.02, and p = 0.003, respectively). Salivary flow rate showed a negative correlation with Na and Cl (p = 0.01 and p = 0.013, respectively). At cGVHD onset, the salivary flow rate showed no statistical difference compared with the other studied periods. A trend was observed in the higher Na concentration compared with the baseline (p = 0.06) and Pi concentration presented a significant decrease (p = 0.004). Ca and Mg concentrations showed no changes during all evaluation periods. The present study showed changes in inorganic salivary components in post-HSCT periods, mainly during the early period post-HSCT and at the cGVHD onset. We speculate that Na, Cl, and Pi in saliva could be used as a potential biomarker in further studies.
authors: Hematology and Blood Transfusion Center, University of Campinas, Rua Carlos Chagas, 480, P.O. Box: 6198, Campinas, SP, 13083-878, Brazil, ccboer@gmail.com.
authors: C C
authors: CC
authors: Boer
authors: M E P
authors: ME
authors: Correa
authors: L M A
authors: LM
authors: Tenuta
authors: C A
authors: CA
authors: Souza
authors: A C
authors: AC
authors: Vigorito
mesh_terms: D000328:Adult; D000368:Aged; D002118:Calcium / Q000032:analysis / Q000378:metabolism; D002712:Chlorides / Q000032:analysis / Q000378:metabolism; D005260:Female; D006086:Graft vs Host Disease / Q000378:metabolism*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008274:Magnesium / Q000737:chemistry / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000032:analysis / Q000378:metabolism; D011188:Potassium / Q000737:chemistry / Q000378:metabolism; D011446:Prospective Studies; D012463:Saliva / Q000737:chemistry / Q000378:metabolism*; D012964:Sodium / Q000032:analysis / Q000378:metabolism; D013280:Stomatitis / Q000209:etiology / Q000378:metabolism; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D002712:Chlorides; D010710:Phosphates; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium
references: Arch Dermatol. 1995 Aug;131(8):964-5
references: 7632078
references: Bone Marrow Transplant. 2012 May;47(5):725-30
references: 21874059
references: Transplantation. 1983 May;35(5):441-6
references: 6342224
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):175-83
references: 16448918
references: J Clin Oncol. 2001 Apr 15;19(8):2201-5
references: 11304772
references: Acta Odontol Scand. 1964 Feb;22:121-35
references: 14158464
references: Dent Clin North Am. 2008 Jan;52(1):79-109, viii-ix
references: 18154866
references: Bone Marrow Transplant. 1996 Mar;17(3):421-3
references: 8704698
references: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Feb;79(2):164-9
references: 7614178
references: J Dent Res. 2004 Feb;83(2):98-103
references: 14742644
references: Acta Otolaryngol Suppl. 2002;(546):134-41
references: 12132611
references: Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56
references: 16338616
references: J Dent Res. 1987 Nov;66(11):1619-22
references: 10872393
references: Int J Oral Maxillofac Surg. 1996 Aug;25(4):298-307
references: 8910118
references: Oral Surg Oral Med Oral Pathol. 1988 Oct;66(4):451-8
references: 3186220
references: J Dent Res. 2006 Sep;85(9):834-8
references: 16931867
references: J Prosthet Dent. 2001 Feb;85(2):162-9
references: 11208206
references: Arch Oral Biol. 1974 Oct;19(10):887-95
references: 4531847
references: J Oral Pathol Med. 2005 Jul;34(6):368-73
references: 15946186
references: Community Dent Oral Epidemiol. 2003 Dec;31 Suppl 1:3-23
references: 15015736
references: Cancer Invest. 2003;21(1):34-40
references: 12643007
references: J Oral Pathol Med. 2005 Sep;34(8):486-93
references: 16091116
references: J Contemp Dent Pract. 2008 Mar 01;9(3):72-80
references: 18335122
references: Acta Odontol Scand. 1963 Dec;21:533-51
references: 14121956
references: Bone Marrow Transplant. 2006 May;37(10 ):955-9
references: 16565740